Article Information
History
- March 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joshua Quan, BKin1,
- Christopher Ma, MD1,
- Remo Panaccione, MPH MD1,
- Lindsay Hracs, PhD1,
- Nastaran Sharifi, MD1,
- Michelle Herauf, MSc1,
- Ante Markovinović, BA1,
- Stephanie Coward, PhD1,
- Joseph W. Windsor, PhD1,
- Léa Caplan, BHSc1,
- Richard J. M. Ingram, MD, PhD1,
- Jamil N. Kanji, MD2,3,4,
- Graham Tipples, PhD2,5,
- Jessalyn K. Holodinsky, PhD6,
- Charles N. Bernstein, MD7,
- Douglas J. Mahoney, PhD8,
- Sasha Bernatsky, MD PhD9,
- Eric I. Benchimol, MD, PhD10,11,12,
- Gilaad G. Kaplan, MD, MPH1,* and
- the STOP COVID-19 in IBD Research Group
- 1Inflammatory Bowel Disease Clinic, Department of Medicine, University of Calgary, Calgary, Alberta
- 2Alberta Precision Laboratories, Public Health Laboratory, Alberta, Canada
- 3Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada
- 4Division of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
- 5Department of Medical Microbiology and Immunology, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada
- 6Department of Clinical Neuroscience, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta
- 7University of Manitoba IBD Clinical and Research Centre and Department of Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
- 8Department of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, Alberta
- 9Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- 10ICES, Toronto, ON, Canada
- 11SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, Canada
- 12Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- ↵*Corresponding Author:
Gilaad G. Kaplan, MD, MPH, FRCPC, Teaching Research and Wellness Building, 3D03-18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada, Tel: 403-220-2293, Fax: 403-270-7307, Email: ggkaplan{at}ucalgary.ca
Author Contributions: GGK has full access to all data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. GGK, CM, JQ, JK, GT, RP conceived and designed the study. GGK, CM, RP, NS, MH, RJI, AM were responsible for clinical data. JK, GT, were responsible for serological data. JQ, GGK, SC, LH analyzed the data. JQ and GK drafted the manuscript. All authors interpreted the data and provided critical revisions of the manuscript for important intellectual content. All authors have approved the final draft of the manuscript.
Posted March 18, 2022.
Serological Responses to the First Three Doses of SARS-CoV-2 Vaccination in Inflammatory Bowel Disease: A Prospective Cohort Study
